🔬 Exciting News! A groundbreaking study by Augusta University, published in Cancers, has highlighted the exceptional utility of combining #OGM and a 523-gene #NGS panel, thus validating #Bionano's OGM workflow. https://t.co/YKprGri4v6 #Genomics#CancerResearch#MyeloidCancers
Nice paper from UCSF and National Taiwan university describing the discovery of a new microdeletion involved in Charcot-Marie-Tooth Disease by optical genome mapping @bionano
https://t.co/6iJ0Gf3od6
$BNGO - Bionano
20-Jun-2023 - Department of Health !!!
Who needs FDA approval when the Department of Health and Human Services specifies OGM as one of the technologies it wants to see used in the submission of 200 high quality human genomes as part of the U.S.'s contribution to the Human Pangenome Project !!!
https://t.co/G1WbOKHou8
For those who are not sure whether in genomics "optical mapping" effectively means Bionano, here is an excellent history of "optical mapping" (OpGen has left the "optical mapping" market, and Nabsys is yet to be in the market after 9 rounds of funding, the latest being last November) :
https://t.co/5FaHm3kZlv
Outstanding presentation by Dr. Adam Smith on #OGM at the IX Symposium of the Spanish Group on Hematological Cytogenetics in Lleida @gcecgh@sehh_es @bionanogenomics
Optical Genome Mapping (OGM) for prenatal genetic testing has 100% concordance with karyotyping and microarray. Cytogenomics lab @UCSFHospitals contributed to this important study. OGM can replace multiple assays. https://t.co/5rISfa1OrZ
$BNGO - Bionano
Study emphasizing the absolute importance of including SVs in clinical practice, cancer molecular biology, pharma R&D.
NGS results were verified & enhanced using, amongst other things, OGM & OGM detected SVs other platforms could not.
https://t.co/jsgwALRbuo
$BNGO - Bionano
BTIG reiterates a BUY on Bionano with a Price Target of $3.50.
Largest institutions as of today :
Vanguard - 31m shares
BlackRock - 21.6m shares
State Street - 11.6m shares
Geode Capital - 5.2m shares
Northern Trust - 2.79m shares
https://t.co/6g1iWXtS4Z
$BNGO - Bionano
One from 11-Jul-2022, National Library of Medicine. Only today appearing on my radar.
"In conclusion, OGM could potentially replace current cytogenomic methodologies for the routine management of CLL patients in the future."
https://t.co/3iuIxKZZ52
$BNGO - Bionano
We have a Medicare claims code in Friday's update from the Dept of Health - these codes will take effect from April 1st, 2023.
It's happening ......
https://t.co/vhkMemgzMY
$BNGO 📣🔥💰Whoah!! New contract $1.1 MIL/8 years? Consumables and maintenance Bionano Saphyr Optical Genome Mapping Netherlands-Leiden Leiden University Medical Center #Bionano#genomics#OGM#saphyr#BNGO
2022/S 238-685001
... https://t.co/hAxaPK83bu
Great poster session today at #ASH22 sharing and exchanging experiences with old friends and new ones. Many Q&A on OGM technology. @AnnaPuiggrosPhD @bionanogenomics @ASH_hematology
Thank you Dr. Kanagal-Shamanna - Great talk at #ASH22 Scientific Workshops! We loved hearing that you found informative biomarkers detected by #OGM that were missed by other standard of care + you were able to detect a case of biallelic TP53 disruption by OGM! #SVsMatter#bionano